Todd A. Trapp - 05 Jan 2022 Form 4 Insider Report for ABIOMED INC

Role
Vice President, CFO
Signature
/s/ Marc A. Began (by power of attorney)
Issuer symbol
N/A
Transactions as of
05 Jan 2022
Net transactions value
-$359,430
Form type
4
Filing time
07 Jan 2022, 15:27:15 UTC
Previous filing
05 Nov 2021
Next filing
06 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock, $0.01 par value Sale $359,430 -1,000 -6.6% $359.43 14,063 05 Jan 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABMD Stock Option (Right to Buy) 7,000 05 Jan 2022 Common Stock 0 $266.39 Direct F2, F3
holding ABMD Stock Option (right to buy) 6,530 05 Jan 2022 Common Stock 0 $223.90 Direct F2, F3
holding ABMD Stock Option (right to buy) 3,737 05 Jan 2022 Common Stock 0 $283.88 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F2 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F3 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4 This price represents the sale price of the transactions on the reported date at $359.43. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.